Holen Sie sich die Stockscreener-App
42.89
0.12%
0.05
Schlusskurs vom Vortag:
$42.84
Offen:
$43.25
24-Stunden-Volumen:
804.00K
Relative Volume:
1.05
Marktkapitalisierung:
$1.74B
Einnahmen:
$399.58M
Nettoeinkommen (Verlust:
$-54.04M
KGV:
-107.22
EPS:
-0.4
Netto-Cashflow:
$40.13M
1W Leistung:
+9.41%
1M Leistung:
+29.85%
6M Leistung:
+106.20%
1J Leistung:
+62.65%
1-Tages-Spanne:
$42.35
$44.16
1-Wochen-Bereich:
$38.13
$44.16
52-Wochen-Spanne:
$18.61
$44.16
Veracyte Inc Stock (VCYT) Company Profile
Firmenname
Veracyte Inc
Sektor
Branche
Telefon
(650) 243-6300
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie VCYT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
42.89 | 1.74B | 399.58M | -54.04M | 40.13M | -0.40 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-16 | Eingeleitet | UBS | Buy |
| 2024-10-10 | Eingeleitet | Guggenheim | Buy |
| 2024-02-23 | Bestätigt | Needham | Buy |
| 2023-01-18 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-11-18 | Fortgesetzt | Goldman | Buy |
| 2021-06-15 | Eingeleitet | Raymond James | Outperform |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2019-07-31 | Eingeleitet | Lake Street | Buy |
| 2019-07-02 | Eingeleitet | Needham | Buy |
| 2018-11-29 | Herabstufung | Janney | Buy → Neutral |
| 2018-10-31 | Hochstufung | Janney | Neutral → Buy |
| 2017-11-07 | Herabstufung | Janney | Buy → Neutral |
| 2017-11-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Fortgesetzt | BTIG Research | Buy |
| 2016-11-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-18 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-11 | Bestätigt | Leerink Partners | Outperform |
| 2013-11-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
Veracyte Stock Soars to 52-Week High, Hits $41.46 By Investing.com - Investing.com Nigeria
Fisher Asset Management LLC Reduces Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte Stock Soars to 52-Week High, Hits $41.46 - Investing.com India
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Advantage Alpha Capital Partners LP - MarketBeat
Algert Global LLC Raises Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Principal Financial Group Inc. Reduces Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Position Cut by Jennison Associates LLC - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Position Boosted by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Insider Sell Alert: Karin Eastham Sells 14,731 Shares of Veracyte Inc (VCYT) - GuruFocus.com
Veracyte director Karin Eastham sells shares worth $564,768 By Investing.com - Investing.com Nigeria
Veracyte director Karin Eastham sells shares worth $564,768 - Investing.com
Segall Bryant & Hamill LLC Has $15.12 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Phocas Financial Corp. Invests $1.79 Million in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte Inc (VCYT) Trading 2.14% Higher on Nov 19 - GuruFocus.com
Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised - MSN
Morgan Stanley Increases Veracyte (NASDAQ:VCYT) Price Target to $28.00 - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Assetmark Inc. - MarketBeat
State of New Jersey Common Pension Fund D Has $2.09 Million Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte initiated with an Outperform at Wolfe on growth, margin potential - TipRanks
First Week of January 2025 Options Trading For Veracyte (VCYT) - Nasdaq
Veracyte (NASDAQ:VCYT) Now Covered by Wolfe Research - MarketBeat
Wolfe Research sets stock target on Veracyte, cites growth potential - Investing.com India
Veracyte initiated with an Outperform at Wolfe Research - TipRanks
Insider Sale: CFO Rebecca Chambers Sells Shares of Veracyte Inc (VCYT) - GuruFocus.com
Veracyte CFO Rebecca Chambers sells $585,663 in company stock - Investing.com
Veracyte director Robert Epstein sells $574,830 in stock - Investing.com
Sumitomo Mitsui Trust Group Inc. Cuts Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Artisan Partners Limited Partnership Bolsters Stake in Veracyte Inc - GuruFocus.com
Veracyte, Inc. (NASDAQ:VCYT) Is About To Turn The Corner - Simply Wall St
Peregrine Asset Advisers Inc. Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Analysts Set Veracyte, Inc. (NASDAQ:VCYT) PT at $39.71 - MarketBeat
Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by AEGON ASSET MANAGEMENT UK Plc - MarketBeat
Wellington Management Group LLP's Strategic Reduction in Veracyte Inc Holdings - GuruFocus.com
Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates - MSN
Veracyte (NASDAQ:VCYT) Stock Price Expected to Rise, Scotiabank Analyst Says - MarketBeat
Veracyte price target raised to $44 from $40 at Scotiabank - TipRanks
Veracyte, Inc. (NASDAQ:VCYT) Q3 2024 Earnings Call Transcript - Insider Monkey
ARK Investment Management LLC Sells 1,888,552 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte stock target lifted, sustains buy rating on strong Q3 results - Investing.com Australia
Veracyte Third Quarter 2024 Earnings: Beats Expectations - Yahoo Canada Finance
Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook By GuruFocus - Investing.com Canada
Earnings call: Veracyte posts record Q3 revenue, raises 2024 guidance By Investing.com - Investing.com Australia
Earnings call: Veracyte posts record Q3 revenue, raises 2024 guidance - Investing.com
Veracyte (NASDAQ:VCYT) Price Target Raised to $38.00 - MarketBeat
Veracyte Inc (VCYT) Shares Up 6.08% on Nov 7 - GuruFocus.com
Veracyte (NASDAQ:VCYT) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Rev - GuruFocus.com
Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook - Yahoo Finance
Veracyte (NASDAQ:VCYT) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Veracyte Inc earnings beat by $0.30, revenue topped estimates - Investing.com Australia
Finanzdaten der Veracyte Inc-Aktie (VCYT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):